RGLS Regulus Therapeutics, Inc. Operating Profitability

RGLS (Regulus Therapeutics, Inc.) - company brandmark

Successes in developing RNA therapies for renal pathologies determine the operating profit margins on the GURU.Markets chart, where 0.00 records a new level. The effective leadership of Jay Hagan has secured capital inflows for scientific research. Meanwhile, operational processes are strictly limited by FDA medical regulations regarding the disposal of biomaterials for Regulus Therapeutics (RGLS).

RGLS: Regulus Therapeutics, Inc. Operating Return on Sales 07/04/2022 - 07/05/2025

Financial and market metric breakdowns for Regulus Therapeutics (RGLS)

- share price and consensus valuation forecast:
Initial company analysis:Regulus, RGLS
Brand item of Regulus

The operating margin reflects the efficiency of the core operations of Regulus Therapeutics (RGLS), representing the share of operating profit in total revenue before accounting for debt and tax obligations. Analyzing this operating margin allows for an assessment of how the fabless model and the outsourcing of production to CMOs optimize costs, which determines the fundamental stability of the business during the development of RNA drugs.

Analysis of competing companies

Operating Sales Margin TEM|QGEN - Operating Profitability Margin|Operating Margin IONS|RGEN - Operating Return on Sales|Operating Profitability Avidity RNA|Operating Margin CRISPR Therapeutics Corp CRSP|GeneDx Corp - Operating Margin|Ultragenyx Pharma (RARE) - Operating Sales Margin|beamtx.com (BEAM) - Operating Profitability|SRPT: Operating Profit Ratio|Operating Sales Margin TWST|TXG - Operating Profitability Margin|Operating Margin NTLA|Profitability of Operations Stoke Therapeutics|Operating Profitability BioLife Solutions BLFS|Wave Life Sciences (WVE) - Operating Return on Sales|Maze Therapeutics, Inc. - Operating Margin|Profitability of Operations Sionna Therapeutics, Inc. SION|Prime Medicine Bio (PRME) - Operating Profitability|TSHA: Operating Profit Ratio|Operating Profitability uniQure Pharma|MGTX - Operating Profitability Margin|Operating Margin RGNX|Operating Profitability SLDB (Solid Biosciences)|Ocugen Corp - Operating Sales Margin|PACB: Return on Sales by Operating Profit|benitec.com - Operating Margin|DSGN - Operating Margin|RCKT: Operating Margin|FDMT (4D Molecular Therapeutics Inc) - Operating Profitability|Operating Sales Margin LXEO|Operating Profitability KRRO|Operating Margin EDIT|SLN - Operating Return on Sales|Operating Margin PRQR (ProQR)|CDXS - Operating Sales Margin|Sangamo Therapeutics Inc. - Operating Margin|NAUT - Operating Margin|MGX: Operating Margin|Operating Sales Margin Precision BioSciences, Inc.|GBIO (Generation Bio) - Operating Margin|Boundless Bio Inc. (BOLD) - Profitability of Operations|Operating Sales Margin XCUR (exicuretx.com)|Imunon Inc - Return on Sales by Operating Profit|Operating Margin PHIO (Phio Pharmaceuticals Corp)|Operating Profit Rate MBIO|RNAZ - Operating Profitability|Operating Profit Rate BNGO (bionanogenomics.com)|Applied DNA Sciences (APDN) - Operating Profitability|Bluebird Bio - Operating Profit Rate|IPA (ImmunoPrecise Antibodies Ltd) - Operating Margin|Operating Return on Sales Omega Therapeutics, Inc. OMGA|Operating Margin OMIC|Operating Sales Margin Syros Pharmaceuticals, Inc. SYRS|Telesis Bio - Operating Sales Margin|Operating Profit Rate TCON|UBX - Operating Profitability